articleTop 10% cited

Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer

Breast Cancer Research and Treatment · 2016 · Vol. 161(2) · pp. 279–287

Xiaoxian Li✉(Emory Healthcare)Jing Yang(Emory University)Limin Peng(Emory University)Ayşegül A. Şahin(The University of Texas MD Anderson Cancer Center)Lei Huo(The University of Texas MD Anderson Cancer Center)Kevin C. Ward(Emory University)Ruth O’Regan(University of Wisconsin–Madison)Mylin A. Torres(Emory University)Jane Meisel(Emory University)

View via DOI Publisher page

Breast Cancer Treatment Studies Global Cancer Incidence and Screening Cancer Genomics and DiagnosticsTriple-negative breast cancerBreast cancerMedicineOncologyInternal medicineCancerStage (stratigraphy)Surveillance, Epidemiology, and End ResultsLymph nodeCancer registry

MeSH terms

AdultAgedBreast NeoplasmsCause of DeathFemaleHumansMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisSEER ProgramTumor BurdenKaplan-Meier EstimateNeoplasm GradingTriple Negative Breast Neoplasms

Citations

535

FWCI

6.94

field-weighted impact

References

Percentile

98%

vs. same field & year

Citations per year

References

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM